Potential Function for the Vector Field

12d

Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)

Ad hoc announcement pursuant to Art. 53 LR Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase III ...

10d

Pacira BioSciences Concludes Patient Enrollment in Part A of Phase 2 Study Evaluating Safety and Efficacy of PCRX-201 for the Treatment of Osteoarthritis of the Knee

Detailed price information for Pacira Pharm Inc (PCRX-Q) from The Globe and Mail including charting and trades.

Pharmabiz

US FDA approves Novartis’ Itvisma, the only gene replacement therapy for children two years and older, teens, and adults with SMA

US FDA approves Novartis’ Itvisma, the only gene replacement therapy for children two years and older, teens, and adults with SMA: Basel Wednesday, November 26, 2025, 09:00 Hrs ...

13d

Novartis receives FDA approval for Itvisma(R), the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)

ITVISMA is a prescription gene therapy used to treat adults and children 2 years of age and older with spinal muscular atrophy (SMA). ITVISMA is given as a one-time intrathecal injection. What is the ...

19d

Intrepid Metals Zeroes in on Potential Porphyry Discovery Beneath Corral Copper CRD System and Continues Delivering Strong Results at Ringo

Detailed price information for Intrepid Metals Corp (INTR-X) from The Globe and Mail including charting and trades.

MarketersMEDIA Newsroom

Novartis Pharma AG: Novartis receives FDA approval for Itvisma, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)

Pacira BioSciences Concludes Patient Enrollment in Part A of Phase 2 Study Evaluating Safety and Efficacy of PCRX-201 for the Treatment of Osteoarthritis of the Knee

US FDA approves Novartis’ Itvisma, the only gene replacement therapy for children two years and older, teens, and adults with SMA

Novartis receives FDA approval for Itvisma(R), the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)

Intrepid Metals Zeroes in on Potential Porphyry Discovery Beneath Corral Copper CRD System and Continues Delivering Strong Results at Ringo

Creative Biogene Launches Advanced Programmable Delivery System Service for Next-Generation Therapeutics

These shapeshifting robots could monitor your body from the inside

REGENXBIO (RGNX) Q3 2025 Earnings Call Transcript

Creativity Key to Slowing Brain Aging

Quantum computing will make cryptography obsolete. But computer scientists are working to make them unhackable.

Novartis Pharma AG: Novartis receives FDA approval for Itvisma, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular ...